Patent applications and USPTO patent grants for DaVinci Biosciences LLC.The latest application filed is for "natural killer cells and methods for enhancing viability, proliferation and cytotoxicity of same following cryopreservation".
Patent | Date |
---|---|
Natural Killer Cells and Methods for Enhancing Viability, Proliferation and Cytotoxicity of Same Following Cryopreservation App 20160186138 - CHELYAPOV; NICKOLAS ;   et al. | 2016-06-30 |
Umbilical cord lining stem cells and methods and material for isolating and culturing same Grant 8,778,679 - Silva , et al. July 15, 2 | 2014-07-15 |
Human Gonadal Stem Cells App 20130252328 - Silva; Francisco ;   et al. | 2013-09-26 |
Umbilical Cord Lining Stem Cells And Methods And Material For Isolating And Culturing Same App 20130065302 - Silva; Francisco J. ;   et al. | 2013-03-14 |
Human Gonadal Stem Cells App 20110008764 - Silva; Francisco J. ;   et al. | 2011-01-13 |
NCAGE Code | 5PN67 | DAVINCI BIOSCIENCES LLC |
CAGE Code | 5PN67 | DAVINCI BIOSCIENCES LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.